Article
Impact of Age on Tumor Mutation Burden in Gastric patients:a secondary analysis based on a cross-sectional study
2019-08-28
Abstract excerpt
<h4>Background: </h4> Gastric carcinoma is aggressive cancer with a poor prognosis. Recent years, immunotherapy has been validated effective in a proportion of patients. Tumor mutational burden (TMB),microsatellite instability (MSI) status and programmed cell death-ligand 1 (PD-L1) expression are potential biomarkers to predict efficacy to immunocheckpoint inhibitors (ICIs). This study was undertaken to explore th...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b5a68f61-6592-5315-9e16-a479d3f8ffcd
- DOI
- 10.21203/rs.2.12421/v1
